One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

Keith J. Sullivan net worth and biography

Keith Sullivan Biography and Net Worth

CEO of Neuronetics

Mr. Sullivan most recently served as Chief Commercial Officer and President (North America) of ZELTIQ Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform under the Coolsculpting® brand, from January 2016 until the acquisition of ZELTIQ by Allergan, Inc. in April 2017. Mr. Sullivan previously served as Senior Vice President and Chief Commercial Officer of ZELTIQ from November 2014 until January 2016 and as Senior Vice President of Worldwide Sales and Marketing from July 2013 through October 2014.
Mr. Sullivan, who has more than 30 years of senior sales leadership experience in the medical device industry, has previously held leadership positions with Medicis Pharmaceuticals, Reliant Technologies, Medtronic, Vision Quest Laser Center and Coherent Medical.
Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary and is a clinical professor in the Mason School of Business at William and Mary. Mr. Sullivan currently serves on the Boards of Directors of Sientra, Inc. and Venus Concept.

What is Keith J. Sullivan's net worth?: The estimated net worth of Keith J. Sullivan is at least $5.54 million as of February 26th, 2024. Mr. Sullivan owns 1,372,278 shares of Neuronetics stock worth more than $5,544,003 as of April 16th. This net worth evaluation does not reflect any other assets that Mr. Sullivan may own. Additionally, Mr. Sullivan receives an annual salary of $1,530,000.00 as CEO at Neuronetics. Learn More about Keith J. Sullivan's net worth.
How old is Keith J. Sullivan?: Mr. Sullivan is currently 66 years old. There are 2 older executives and no younger executives at Neuronetics. Learn More on Keith J. Sullivan's age.
What is Keith J. Sullivan's salary?: As the CEO of Neuronetics, Inc., Mr. Sullivan earns $1,530,000.00 per year. Learn More on Keith J. Sullivan's salary.
How do I contact Keith J. Sullivan?: The corporate mailing address for Mr. Sullivan and other Neuronetics executives is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. Neuronetics can also be reached via phone at (610) 640-4202 and via email at [email protected]. Learn More on Keith J. Sullivan's contact information.
Has Keith J. Sullivan been buying or selling shares of Neuronetics?: Keith J. Sullivan has not been actively trading shares of Neuronetics during the past quarter. Most recently, Keith J. Sullivan sold 20,292 shares of the business's stock in a transaction on Monday, February 26th. The shares were sold at an average price of $3.30, for a transaction totalling $66,963.60. Following the completion of the sale, the chief executive officer now directly owns 1,372,278 shares of the company's stock, valued at $4,528,517.40. Learn More on Keith J. Sullivan's trading history.
Who are Neuronetics' active insiders?: Neuronetics' insider roster includes Robert Cascella (Director), Sheryl Conley (Director), Stephen Furlong (CFO), Gregory Harper (VP), William Macan (VP), Bruce Shook (Director), and Keith Sullivan (CEO). Learn More on Neuronetics' active insiders.
Are insiders buying or selling shares of Neuronetics?: In the last twelve months, insiders at the sold shares 17 times. They sold a total of 202,262 shares worth more than $610,676.94. The most recent insider tranaction occured on February, 28th when EVP William Andrew Macan sold 22,377 shares worth more than $70,711.32. Insiders at Neuronetics own 5.2% of the company. Learn More about insider trades at Neuronetics.
Information on this page was last updated on 2/28/2024.

Keith J. Sullivan Insider Trading History at Neuronetics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/26/2024	Sell	20,292	$3.30	$66,963.60	1,372,278
2/22/2024	Sell	20,851	$3.23	$67,348.73	1,413,320
2/20/2024	Sell	23,958	$2.96	$70,915.68	1,434,171
1/10/2024	Sell	10,013	$3.01	$30,139.13	1,167,645
7/21/2023	Sell	6,551	$2.04	$13,364.04	1,177,658
7/19/2023	Sell	6,479	$2.07	$13,411.53	1,190,719
2/13/2023	Sell	25,154	$5.49	$138,095.46	1,210,845
7/18/2022	Sell	63,466	$3.72	$236,093.52	850,999
7/15/2021	Sell	50,893	$13.46	$685,019.78	630,646
1/26/2021	Sell	22,829	$18.83	$429,870.07	602,171

Keith J. Sullivan Buying and Selling Activity at Neuronetics

Neuronetics Company Overview

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Today's Range

Now: $4.04

$4.00

$4.18

50 Day Range

MA: $3.87

$2.79

$4.81

2 Week Range

Now: $4.04

$1.03

$5.07

Volume

25,385 shs

Average Volume

194,918 shs

Market Capitalization

$121.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.44

Can't believe it's happening again

From Manward Press | Ad

We explain how this event works in full right here.

Keith Sullivan Biography and Net Worth

What is Keith J. Sullivan's net worth?

How old is Keith J. Sullivan?

What is Keith J. Sullivan's salary?

How do I contact Keith J. Sullivan?

Has Keith J. Sullivan been buying or selling shares of Neuronetics?

Who are Neuronetics' active insiders?

Are insiders buying or selling shares of Neuronetics?